Neupogen and Quinapril drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Neupogen (filgrastim) and Quinapril (quinapril hydrochloride). Common drug interactions include ageusia among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Neupogen and Quinapril. It is created by eHealthMe based on reports of 28 people who take the same drugs from the FDA, and is updated regularly.

What is Neupogen?

Neupogen has active ingredients of filgrastim. It is often used in agranulocytosis. eHealthMe is studying from 23,898 Neupogen users. Check the latest studies of Neupogen.

What is Quinapril?

Quinapril has active ingredients of quinapril hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 12,927 Quinapril users. Check the latest studies of Quinapril.



On Jul, 04, 2026

28 people who take Neupogen and Quinapril together, and have interactions are studied.

Neupogen and Quinapril drug interactions.

What are the common drug interactions of Neupogen and Quinapril, by gender? *:

female:

  1. Ageusia (loss of taste functions of the tongue)
  2. Blood creatinine increased
  3. Blood urea increased
  4. Diarrhoea
  5. Dysgeusia (disorder of the sense of taste)
  6. Gastric perforation (hole in stomach)
  7. Hypotension (abnormally low blood pressure)
  8. Intestinal obstruction
  9. Nephropathy toxic (damage to kidney due to toxins)
  10. Renal failure (kidney dysfunction)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Paronychia (infection in the tissues adjacent to a nail on a finger or toe)
  4. Anaemia (lack of blood)
  5. Back pain
  6. Bone erosion
  7. Dental caries
  8. Fall
  9. Groin pain
  10. Neck pain

What are the common drug interactions of Neupogen and Quinapril, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Ageusia (loss of taste functions of the tongue)
  2. Dysgeusia (disorder of the sense of taste)

40-49:

n/a

50-59:

  1. Malignant pericardial neoplasm (cancer tumour of heart muscle)
  2. Mass
  3. Metastases to large intestine (cancer spreads to large intestine)
  4. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  5. Myositis (inflammation of the muscles)
  6. Nausea (feeling of having an urge to vomit)
  7. Neck pain
  8. Nephrolithiasis (calculi in the kidneys)
  9. Nephropathy toxic (damage to kidney due to toxins)
  10. Neuropathy peripheral (surface nerve damage)

60+:

  1. Cerebellar haemorrhage (bleeding in cerebeller)
  2. Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
  3. Abdominal pain upper
  4. Alanine aminotransferase increased
  5. Anaemia (lack of blood)
  6. Blood alkaline phosphatase nos increased
  7. Bone marrow leukaemic cell infiltration
  8. Diarrhoea
  9. Dizziness
  10. Dysgeusia (disorder of the sense of taste)

What are the existing conditions these people have? *

  1. Multiple Myeloma (cancer of the plasma cells): 12 people, 42.86%
  2. Metastases To Bone (cancer spreads to bone): 10 people, 35.71%
  3. Lung Cancer - Non-Small Cell (lung cancer): 5 people, 17.86%
  4. Diabetes: 4 people, 14.29%
  5. Rashes (redness): 3 people, 10.71%
  6. Oedema (fluid collection in tissue): 3 people, 10.71%
  7. Neuropathy Peripheral (surface nerve damage): 3 people, 10.71%
  8. High Blood Cholesterol: 3 people, 10.71%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 10.71%
  10. Dyspnea (difficult or laboured breathing): 3 people, 10.71%

* Approximation only. Some reports may have incomplete information.

Do you take Neupogen and Quinapril?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Neupogen and Quinapril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Neupogen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Quinapril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Neupogen and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Quinapril and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on filgrastim and quinapril hydrochloride (the active ingredients of Neupogen and Quinapril, respectively), and Neupogen and Quinapril (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: